Jon Snodgres - Oct 7, 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Oct 7, 2022
Transactions value $
$27,736
Form type
4
Date filed
10/11/2022, 05:00 PM
Previous filing
Aug 17, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $27.7K +466 +1.35% $59.52 35K Oct 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +466 +28.38% $0.00 2.11K Oct 7, 2022 Common Stock 466 $59.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of options was effected pursuant to a 10(b)5-1 trading plan adopted on September 6, 2022.
F2 This option is fully vested and exercisable.